LLP homolog, long-term synaptic facilitation pseudogene (LLPH pseudogene)

LLP homolog, long-term synaptic facilitation pseudogene (ENSG00000285531) is a human pseudogene derived from the LLPH gene. According to standard nomenclature, a pseudogene is defined as a genomic sequence similar to a functional gene but is rendered non-functional by mutations and does not encode a full-length, functional protein product[2][5]. Pseudogenes may occasionally be transcribed, and their RNA products can (in rare cases) have regulatory roles, such as acting as miRNA sponges or producing regulatory RNAs, but for this specific locus, there is no established evidence of functional roles[4][5][6]. This gene is not a known receptor, enzyme, transporter, or viable therapeutic target. This gene is a pseudogene; it is not a protein-coding gene and is not recognized as a druggable or therapeutic target[1][2][5]. No evidence links this specific pseudogene to clinical biomarker status, safety concerns, or any approved drugs. The current scientific consensus does not consider pseudogenes, including ENSG00000285531, as canonical targets for pharmacological intervention. If a structured response or ontology for target assessment is required, this entry should be flagged as a non-target (pseudogene, non-coding, non-functional for drug discovery purposes).

Other names

LLPH pseudogeneLLP homolog, long-term synaptic facilitation (LLPH) pseudogene